Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université de Sherbrooke

$30,000.00

Regulation of MHC class II genes and molecules

EF 2008-09

Résumé
The proposed research program is focused on fundamental molecular mechanisms controlling the expression of Major histocompatibility class II (MHC-II) genes and the intracellular transport of MHC-II molecules. MHC-II molecules serve as antigen presenting molecules for CD4-positive T cells, which play a central role for the adaptive immune response, since they modulate most of the immune reactions, such as activation of B cell, macrophages and CD8-positive cytotoxic T cells. Both MHC-II genes and molecules are subject to multiple levels of control, which are essential for the correct function of the immune response and thus present a very interesting and relevant model system for the study of multi-layered regulatory circuits. MARCH protein ubiquitin ligases have emerged as a novel class of immunomodulators that are still poorly understood. We have shown recently that MARCH1 is essential for the IL-10-induced down-regulation of MHC-II molecules expression in monocytes. One of our main interests for the future will be to study the molecular mechanisms of modulation of MHC-II molecule intracellular transport by MARCH proteins. Very little is known about the regulation of MARCH genes and we will study their regulation in different cell types and after exposure to various stimuli. We will also study the function of different isoforms generated by alternative promoters. The majority of positive and negative regulatory mechanisms of MHC-II genes expression are orchestrated directly or indirectly by the MHC-II transactivator CIITA. We have found recently that the extreme N-terminal end of CIITA is both necessary for degradation and transcriptional activation. CIITA is a large non-DNA-binding transcriptional activator and its mode of action is only partially understood. We propose to carry out detailed analysis of its central GTP binding domain, which is important for subcellular transport and transactivation. We also propose to identify proteins interacting with CIITA via a novel genetic approach.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
262845-2008
Name nom
Steimle, Viktor
Department département
Biologie
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2008
Award amount
30000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
33
Committee name en
Molec. & Develop. Genetics
Committee name fr
Gén. moléculaire et dévelop.
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5300
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Molecular biology
Research subject fr
Biologie moléculaire
Partie
1
Nb partie
2
Application title
Regulation of MHC class II genes and molecules
Keyword
NA
Application summary
The proposed research program is focused on fundamental molecular mechanisms controlling the expression of Major histocompatibility class II (MHC-II) genes and the intracellular transport of MHC-II molecules. MHC-II molecules serve as antigen presenting molecules for CD4-positive T cells, which play a central role for the adaptive immune response, since they modulate most of the immune reactions, such as activation of B cell, macrophages and CD8-positive cytotoxic T cells. Both MHC-II genes and molecules are subject to multiple levels of control, which are essential for the correct function of the immune response and thus present a very interesting and relevant model system for the study of multi-layered regulatory circuits. MARCH protein ubiquitin ligases have emerged as a novel class of immunomodulators that are still poorly understood. We have shown recently that MARCH1 is essential for the IL-10-induced down-regulation of MHC-II molecules expression in monocytes. One of our main interests for the future will be to study the molecular mechanisms of modulation of MHC-II molecule intracellular transport by MARCH proteins. Very little is known about the regulation of MARCH genes and we will study their regulation in different cell types and after exposure to various stimuli. We will also study the function of different isoforms generated by alternative promoters. The majority of positive and negative regulatory mechanisms of MHC-II genes expression are orchestrated directly or indirectly by the MHC-II transactivator CIITA. We have found recently that the extreme N-terminal end of CIITA is both necessary for degradation and transcriptional activation. CIITA is a large non-DNA-binding transcriptional activator and its mode of action is only partially understood. We propose to carry out detailed analysis of its central GTP binding domain, which is important for subcellular transport and transactivation. We also propose to identify proteins interacting with CIITA via a novel genetic approach.